Viatris VTRS, a global healthcare company, is scheduled to report fourth-quarter and full-year 2024 results on Feb. 27, 2025. The Zacks Consensus Estimate for revenues is pegged at $3.60 billion, ...
“The 2024 breach included 12 million unique email addresses along with IP and physical addresses, names, usernames, phone ...
Research analysts at Zacks Research lowered their Q4 2025 earnings estimates for Williams-Sonoma in a research report issued ...
EQT Corporation (EQT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...
Today, Zacks Investment Ideas feature highlights Super Micro Computer SMCI and Vertiv VRT. Ride the AI Infrastructure B ...
Analysts at Zacks Research increased their Q2 2025 earnings per share estimates for shares of Alexandria Real Estate Equities ...
These numbers represent the bottom-up aggregates for the index. In other words, we take the earnings estimates of the ...
BEDMINSTER, N.J. (AP) — BEDMINSTER, N.J. (AP) — Intra-Cellular Therapies Inc. (ITCI) on Friday reported a loss of $16.9 million in its fourth quarter. On a per-share basis, the Bedminster, New ...
Let’s delve deeper. Southward Earnings Estimate Revision: The Zacks Consensus Estimate for current-quarter earnings has ...